Discover 700 paid clinical trials in Oklahoma. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Oklahoma offers many options for individuals interested in paid research studies as both healthy participants and those with specific health conditions. Leading research centers in Oklahoma City, Tulsa, and Norman are recruiting volunteers, giving access to the latest treatments and specialized care.
Filter
1
Filter results
Results: 700
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: New York NY, New Brunswick NJ, Orlando FL,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT05932862
Phase 1, Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Get alerts for new trials in your area by subscribing now
Study of SGR-3515 In Participants With Advanced Solid Tumors.
for
Advanced Solid Tumor
Location: New Haven CT, New York NY, Fairfax VA, Toronto,
Sponsor: Schrödinger, Inc.
Sex: All
Age: 18+
Code: NCT06463340
Phase 1, Recruiting
Interactive Voice Based Administration of the GAD 7
for
General Anxiety Disorder
Location: Tulsa OK
Sponsor: Oklahoma State University Center for Health Sciences
Sex: All
Age: 18+
Code: NCT04990492
Recruiting
Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation
for
Asthma in Children, Asthma Attack
Location: Oklahoma City OK
Sponsor: University of Oklahoma
Sex: All
Age: 5 - 17
Code: NCT06137040
Early Phase 1, Recruiting
Research Study of Nutritional Methods to Reduce Body Fat Percentages in Overweight and Obese Populations
for
Obesity
Location: Edmond OK
Sponsor: Central FITT, Inc
Sex: All
Age: 25 - 45
Code: NCT00487344
Phase 1, Recruiting
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Location: Boston MA, New York NY, Richmond VA, Columbus OH,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18+
Code: NCT03564340
Phase 1, Phase 2, Recruiting
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
for
Prostate Cancer
Location: Hampton VA, Warrenville IL, Oklahoma City OK,
Sponsor: Proton Collaborative Group
Sex: Male
Age: 18+
Code: NCT01492972
Phase 3, Recruiting
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
for
Stroke, Stroke, Acute, Stroke, Ischemic
Location: Boston MA, Hartford CT, New Haven CT, New York NY,
Sponsor: University of Cincinnati
Sex: All
Age: 18+
Code: NCT05911568
Recruiting
Registry Study for Radiation Therapy Outcomes
for
Neoplasms
Location: New York NY, Somerset NJ, Hampton VA, Baltimore MD,
Sponsor: Proton Collaborative Group
Sex: All
Age: 0+
Code: NCT01255748
Recruiting
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
for
Deep Venous Thrombosis
Location: New Haven CT, Valhalla NY, New York NY, Philadelphia PA,
Sponsor: Yale University
Sex: All
Age: 0 - 17
Code: NCT04924322
Phase 2, Phase 3, Recruiting
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
for
Lower Respiratory Tract Infection, Parainfluenza,
Location: Boston MA, New York NY, Richmond VA, Durham NC,
Sponsor: Ansun Biopharma, Inc.
Sex: All
Age: 0+
Code: NCT03808922
Phase 3, Recruiting
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
for
Prostate Cancer, Prostatic Neoplasms
Location: New York NY, Albany NY, Myrtle Beach SC, Durham NC,
Sponsor: Clarity Pharmaceuticals Ltd
Sex: Male
Age: 18+
Code: NCT06056830
Phase 3, Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT06401330
Phase 3, Recruiting
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
for
Type 2 Diabetes
Location: New Haven CT, Hyde Park NY, Philadelphia PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 10 - 17
Code: NCT06739122
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
for
Systemic Lupus Erythematosus
Location: Rimouski, Quebec, Manhasset NY, New York NY,
Sponsor: UCB Biopharma SRL
Sex: All
Age: 16+
Code: NCT06617325
Phase 3, Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease